Stockscreener 앱 받기
1.60
1.23%
-0.02
Medicinova Inc 주식(MNOV)의 최신 뉴스
Performance Recap: Is MediciNova Inc backed by strong institutional buyingLong Setup & Daily Profit Maximizing Tips - baoquankhu1.vn
MediciNova (MNOV) Price Target Increased by 28.57% to 9.18 - Nasdaq
Drug Developer Uncovers Excellent Progress in 200-Patient ALS Study - streetwisereports.com
Trading Action: Is MediciNova Inc. a stock for growth or value investorsBond Market & Verified Momentum Stock Ideas - baoquankhu1.vn
Biopharma Reaches 50% Enrollment in New ALS Drug Program - streetwisereports.com
MediciNova, Inc. (NASDAQ:MNOV) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
D. Boral Capital Reaffirms “Buy” Rating for MediciNova (NASDAQ:MNOV) - Defense World
MediciNova's (MNOV) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
MediciNova reaches 50% enrollment milestone in ALS drug study By Investing.com - Investing.com Nigeria
MediciNova reaches 50% enrollment milestone in ALS drug study - Investing.com
ALS patients gain wider access as MediciNova trial reaches 100 enrollees - stocktitan.net
MediciNova Activates SEANOBI Study with 100 Patient Enrollments - intellectia.ai
MediciNova (NASDAQ:MNOV) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
Institution Moves: What are the risks of holding Real Messenger CorporationTrade Ideas & Consistent Return Investment Signals - baoquankhu1.vn
MNOVMediciNova Reports Third Quarter 2011 Results - ADVFN
Dip Buying: Can MediciNova Inc continue delivering strong returnsTrade Signal Summary & Short-Term High Return Ideas - baoquankhu1.vn
MediciNova Announces Additional Analyses from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 30th Int... - ADVFN
MediciNova (NASDAQ:MNOV) Share Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
MediciNova (NASDAQ:MNOV) Share Price Crosses Above 200 Day Moving Average – Should You Sell? - Defense World
Price Action: How sensitive is MediciNova Inc to inflationMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Aug Patterns: Why MediciNova Inc. stock could benefit from AI revolutionMarket Growth Summary & Long-Term Capital Growth Strategies - Bộ Nội Vụ
Rate Hike: Why MediciNova Inc. stock could benefit from AI revolution2025 Trading Recap & Accurate Buy Signal Alerts - Bộ Nội Vụ
Columbia University/New York State Psychiatric Institute and MediciNova Report Preliminary Safety and Efficacy of Ibudilast in H - ADVFN
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver - ADVFN
FDA Grants Fast Track Designation for MediciNova's MN-166 (ibudilast) for the Treatment of Methamphetamine Dependence - ADVFN
Insider Buy: Will MediciNova Inc stock outperform value stocksJuly 2025 Action & Low Volatility Stock Recommendations - moha.gov.vn
Why MediciNova Inc. stock could benefit from AI revolutionMarket Trend Report & Expert Approved Momentum Trade Ideas - Улправда
Will MediciNova Inc. stock beat EPS estimatesPortfolio Gains Summary & Weekly High Conviction Trade Ideas - Улправда
MediciNova Receives a Notice of Allowance for a Method of Treating Drug Addiction or Dependence - ADVFN
Whale Trades: Why MediciNova Inc. stock could benefit from AI revolutionBear Alert & AI Driven Price Forecasts - Улправда
Is MediciNova Inc. stock a good choice for value investors2025 Support & Resistance & Precise Swing Trade Alerts - Улправда
Is MediciNova Inc. stock a dividend growth opportunityJuly 2025 Retail & AI Enhanced Execution Alerts - Улправда
Short Covering: Will MediciNova Inc. stock outperform value stocksTrade Ideas & Free Expert Verified Stock Movement Alerts - ulpravda.ru
MediciNova (NASDAQ:MNOV) Rating Increased to Strong-Buy at Lucid Cap Mkts - MarketBeat
MediciNova, Inc. Provides Shareholder Update on Clinical Trials and Strategic Developments for 2026 - Quiver Quantitative
2026 New Year’s Greetings from the CEO - The Manila Times
MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – What’s Next? - Defense World
MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature’... - ADVFN
Retail Trends: Is MediciNova Inc stock a top pick in earnings seasonWeekly Profit Recap & High Conviction Buy Zone Picks - moha.gov.vn
4875.T Jumps 8.7% Today: Positive Momentum in Biotech - Meyka
MediciNova enters $50 million equity distribution agreement with Lucid Capital - Investing.com Nigeria
MediciNova Inc enters $50 million equity distribution agreement with Lucid Capital Markets - MarketScreener
Medicinova IncOn Dec 29, Entered $50 Million Equity Distribution Agreement With Lucid Capital Markets- SEC Filing - TradingView — Track All Markets
MediciNova Establishes Flexible At-The-Market Equity Program - TipRanks
MediciNova enters $50 million equity distribution agreement with Lucid Capital By Investing.com - Investing.com South Africa
MediciNova Signs Equity Distribution Agreement With Lucid Capital Markets - TradingView — Track All Markets
Form 424B5 MEDICINOVA INC - StreetInsider
MediciNova, Inc. (NASDAQ:MNOV) Sees Large Decline in Short Interest - MarketBeat
Is MediciNova Inc. stock a top pick in earnings seasonWeekly Investment Summary & Growth Focused Entry Point Reports - Bölüm Sonu Canavarı
Will MediciNova Inc. stock outperform value stocksDollar Strength & Real-Time Stock Movement Alerts - DonanımHaber
MediciNova (NASDAQ:MNOV) Receives Buy Rating from D. Boral Capital - Defense World
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - Nasdaq
0.23%
1.25%
자본화:
|
볼륨(24시간):